These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22640434)

  • 21. Chemical peeling in ethnic/dark skin.
    Roberts WE
    Dermatol Ther; 2004; 17(2):196-205. PubMed ID: 15113287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical agents used in the management of hyperpigmentation.
    Halder RM; Richards GM
    Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
    Chaudhary S; Dayal S
    J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
    Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
    Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Insights in Melasma and Hyperpigmentation Management.
    Huerth KA; Hassan S; Callender VD
    J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
    J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of a superficial chemical peel combined with a multimodal, hydroquinone-free skin brightener using in vivo reflectance confocal microscopy.
    Goberdhan LT; Mehta RC; Aguilar C; Makino ET; Colvan L
    J Drugs Dermatol; 2013 Mar; 12(3):S38-41. PubMed ID: 23545932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
    Nanda S; Grover C; Reddy BS
    Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser.
    Bellew SG; Alster TS
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):555-8. PubMed ID: 15056151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melasma. Etiologic and therapeutic considerations.
    Grimes PE
    Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.
    Davis EC; Callender VD
    J Clin Aesthet Dermatol; 2010 Jul; 3(7):20-31. PubMed ID: 20725554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postinflammatory hyperpigmentation: evolving combination treatment strategies.
    Taylor SC; Burgess CM; Callender VD; Fu J; Rendon MI; Roberts WE; Shalita AR
    Cutis; 2006 Aug; 78(2 Suppl 2):6-19. PubMed ID: 16977792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
    Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
    J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of hydroquinone with facial laser resurfacing.
    Goldman MP
    J Cutan Laser Ther; 2000 Jun; 2(2):73-7. PubMed ID: 11360320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions for acne scars.
    Abdel Hay R; Shalaby K; Zaher H; Hafez V; Chi CC; Dimitri S; Nabhan AF; Layton AM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011946. PubMed ID: 27038134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
    Spierings NMK
    J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acne in skin of color: practical approaches to treatment.
    Shah SK; Alexis AF
    J Dermatolog Treat; 2010 May; 21(3):206-11. PubMed ID: 20132053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment.
    Roberts WE
    J Drugs Dermatol; 2014 Apr; 13(4):472-82. PubMed ID: 24719068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
    Sofen B; Prado G; Emer J
    Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hyperpigmentation.
    Woolery-Lloyd H; Kammer JN
    Semin Cutan Med Surg; 2011 Sep; 30(3):171-5. PubMed ID: 21925372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.